Epigenetic mechanisms in amyotrophic lateral sclerosis: A short review

[1]  Upcoming Meetings Related to Huntington's Disease. , 2019, Journal of Huntington's disease.

[2]  Kotb Abdelmohsen,et al.  Noncoding RNAs in Alzheimer's disease , 2018, Wiley interdisciplinary reviews. RNA.

[3]  N. Rezaei,et al.  MicroRNA in Alzheimer’s disease revisited: implications for major neuropathological mechanisms , 2018, Reviews in the neurosciences.

[4]  A. Chiò,et al.  Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications , 2018, The Lancet Neurology.

[5]  L. Petrucelli,et al.  Unaffected mosaic C9orf72 case , 2017, Neurology.

[6]  T. Matsuura,et al.  Alpha-1 antichymotrypsin is involved in astrocyte injury in concert with arginine-vasopressin during the development of acute hepatic encephalopathy , 2017, PloS one.

[7]  Y. Suh,et al.  Comprehensive miRNA Profiling of Skeletal Muscle and Serum in Induced and Normal Mouse Muscle Atrophy During Aging , 2017, The journals of gerontology. Series A, Biological sciences and medical sciences.

[8]  C. Angelini,et al.  Micro-RNAs in ALS muscle: Differences in gender, age at onset and disease duration , 2017, Journal of the Neurological Sciences.

[9]  S. Bandyopadhyay,et al.  Biological networks in Parkinson’s disease: an insight into the epigenetic mechanisms associated with this disease , 2017, BMC Genomics.

[10]  Christian A. Ross,et al.  Conserved DNA methylation combined with differential frontal cortex and cerebellar expression distinguishes C9orf72-associated and sporadic ALS, and implicates SERPINA1 in disease , 2017, Acta Neuropathologica.

[11]  C. Suter,et al.  Epigenetic differences between monozygotic twins discordant for amyotrophic lateral sclerosis (ALS) provide clues to disease pathogenesis , 2017, PloS one.

[12]  Young-Kook Kim,et al.  Identification of the Role of miR-142-5p in Alzheimer’s Disease by Comparative Bioinformatics and Cellular Analysis , 2017, Front. Mol. Neurosci..

[13]  E. Goodall,et al.  Serum miRNAs miR-206, 143-3p and 374b-5p as potential biomarkers for amyotrophic lateral sclerosis (ALS) , 2017, Neurobiology of Aging.

[14]  A. M. Correia,et al.  Downregulated Glia Interplay and Increased miRNA-155 as Promising Markers to Track ALS at an Early Stage , 2017, Molecular Neurobiology.

[15]  Saumya Das,et al.  miR-29b contributes to multiple types of muscle atrophy , 2017, Nature Communications.

[16]  J. Rutledge,et al.  DNA methylation alterations in Alzheimer’s disease , 2017, Environmental epigenetics.

[17]  Sarah Martin,et al.  The changing picture of amyotrophic lateral sclerosis: lessons from European registers , 2017, Journal of Neurology, Neurosurgery, and Psychiatry.

[18]  T. B. Hansen,et al.  Biogenesis and Function of Ago-Associated RNAs. , 2017, Trends in genetics : TIG.

[19]  D. Mari,et al.  Transcriptional and epigenetic phenomena in peripheral blood cells of monozygotic twins discordant for alzheimer’s disease, a case report , 2017, Journal of the Neurological Sciences.

[20]  Hong Qing,et al.  Epigenetics in Alzheimer’s Disease: Perspective of DNA Methylation , 2017, Molecular Neurobiology.

[21]  Jane Y. Wu,et al.  PINK1 and Parkin are genetic modifiers for FUS-induced neurodegeneration. , 2016, Human molecular genetics.

[22]  Patricia M. Garay,et al.  Yin-yang actions of histone methylation regulatory complexes in the brain. , 2016, Epigenomics.

[23]  M. Rietschel,et al.  Epigenome-wide DNA methylation analysis in siblings and monozygotic twins discordant for sporadic Parkinson’s disease revealed different epigenetic patterns in peripheral blood mononuclear cells , 2016, neurogenetics.

[24]  M. Pellegrini,et al.  Epigenetic changes in T‐cell and monocyte signatures and production of neurotoxic cytokines in ALS patients , 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[25]  B. Carvalho,et al.  MicroRNAs-424 and 206 are potential prognostic markers in spinal onset amyotrophic lateral sclerosis , 2016, Journal of the Neurological Sciences.

[26]  Ivan Dikic,et al.  Common Molecular Pathways in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. , 2016, Trends in molecular medicine.

[27]  T. Outeiro,et al.  The yin and yang of α-synuclein-associated epigenetics in Parkinson's disease. , 2016, Brain : a journal of neurology.

[28]  H. Shang,et al.  Aberration of miRNAs Expression in Leukocytes from Sporadic Amyotrophic Lateral Sclerosis , 2016, Front. Mol. Neurosci..

[29]  S. Horvath,et al.  Huntington's disease accelerates epigenetic aging of human brain and disrupts DNA methylation levels , 2016, Aging.

[30]  O. Ross,et al.  Epigenetic regulation in Parkinson’s disease , 2016, Acta Neuropathologica.

[31]  A. Dávalos,et al.  Circulating microRNAs in Huntington's disease: Emerging mediators in metabolic impairment. , 2016, Pharmacological research.

[32]  S. M. Kolk,et al.  MicroRNA-338 Attenuates Cortical Neuronal Outgrowth by Modulating the Expression of Axon Guidance Genes , 2016, Molecular Neurobiology.

[33]  E. Rogaeva,et al.  Genetic and epigenetic study of ALS-discordant identical twins with double mutations in SOD1 and ARHGEF28 , 2016, Journal of Neurology, Neurosurgery & Psychiatry.

[34]  Ashley R. Jones,et al.  Identification of miRNAs as Potential Biomarkers in Cerebrospinal Fluid from Amyotrophic Lateral Sclerosis Patients , 2016, NeuroMolecular Medicine.

[35]  J. Hur,et al.  Expression of microRNAs in human post-mortem amyotrophic lateral sclerosis spinal cords provides insight into disease mechanisms , 2016, Molecular and Cellular Neuroscience.

[36]  D. Standaert,et al.  microRNA-155 Regulates Alpha-Synuclein-Induced Inflammatory Responses in Models of Parkinson Disease , 2016, The Journal of Neuroscience.

[37]  P. Bauer.  Methylation of C9orf72 expansion reduces RNA foci formation and dipeptide-repeat proteins expression in cells , 2016, Neuroscience Letters.

[38]  A. McArdle,et al.  Age‐related changes in miR‐143‐3p:Igfbp5 interactions affect muscle regeneration , 2016, Aging cell.

[39]  J. Sanchez-Mut,et al.  Epigenetic Alterations in Alzheimer’s Disease , 2015, Front. Behav. Neurosci..

[40]  S. Horvath,et al.  Increased epigenetic age and granulocyte counts in the blood of Parkinson's disease patients , 2015, Aging.

[41]  M. Levine,et al.  Epigenetic age of the pre-frontal cortex is associated with neuritic plaques, amyloid load, and Alzheimer’s disease related cognitive functioning , 2015, Aging.

[42]  B. Zuo,et al.  MicroRNA, miR-374b, directly targets Myf6 and negatively regulates C2C12 myoblasts differentiation. , 2015, Biochemical and biophysical research communications.

[43]  H. Fröhlich,et al.  L‐dopa increases α‐synuclein DNA methylation in Parkinson's disease patients in vivo and in vitro , 2015, Movement disorders : official journal of the Movement Disorder Society.

[44]  C. Broeckhoven,et al.  The C9orf72 repeat size correlates with onset age of disease, DNA methylation and transcriptional downregulation of the promoter , 2015, Molecular Psychiatry.

[45]  D. Dykxhoorn,et al.  Bromodomain inhibitors regulate the C9ORF72 locus in ALS , 2015, Experimental Neurology.

[46]  K. Mitchelson,et al.  Roles of the canonical myomiRs miR-1, -133 and -206 in cell development and disease. , 2015, World journal of biological chemistry.

[47]  E. Izaurralde,et al.  Towards a molecular understanding of microRNA-mediated gene silencing , 2015, Nature Reviews Genetics.

[48]  Juhyun Song,et al.  miR-155 is involved in Alzheimer’s disease by regulating T lymphocyte function , 2015, Front. Aging Neurosci..

[49]  M. Grossman,et al.  C9orf72 promoter hypermethylation is neuroprotective , 2015, Neurology.

[50]  S. Sorbi,et al.  The C9orf72 repeat expansion itself is methylated in ALS and FTLD patients , 2015, Acta Neuropathologica.

[51]  N. Pochet,et al.  Targeting miR‐155 restores abnormal microglia and attenuates disease in SOD1 mice , 2015, Annals of neurology.

[52]  A. Singleton,et al.  Identical twins with the C9orf72 repeat expansion are discordant for ALS , 2014, Neurology.

[53]  Nicolas Stifani,et al.  Motor neurons and the generation of spinal motor neuron diversity , 2014, Front. Cell. Neurosci..

[54]  R. D'Alessandro,et al.  miR-338-3p is over-expressed in blood, CFS, serum and spinal cord from sporadic amyotrophic lateral sclerosis patients , 2014, neurogenetics.

[55]  V. Kim,et al.  Regulation of microRNA biogenesis , 2014, Nature Reviews Molecular Cell Biology.

[56]  E. Li,et al.  DNA methylation in mammals. , 2014, Cold Spring Harbor perspectives in biology.

[57]  P. Popovich,et al.  Microglia Induce Motor Neuron Death via the Classical NF-κB Pathway in Amyotrophic Lateral Sclerosis , 2014, Neuron.

[58]  E. Beghi,et al.  Whole-blood global DNA methylation is increased in amyotrophic lateral sclerosis independently of age of onset , 2014, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[59]  I. Arisi,et al.  Dysregulated microRNAs in amyotrophic lateral sclerosis microglia modulate genes linked to neuroinflammation , 2013, Cell Death and Disease.

[60]  D. Rubinsztein,et al.  NeuroGeM, a knowledgebase of genetic modifiers in neurodegenerative diseases , 2013, BMC Medical Genomics.

[61]  L. Petrucelli,et al.  Reduced C9orf72 gene expression in c9FTD/ALS is caused by histone trimethylation, an epigenetic event detectable in blood , 2013, Acta Neuropathologica.

[62]  S. Horvath.  DNA methylation age of human tissues and cell types , 2013, Genome Biology.

[63]  V. Meininger,et al.  Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression. , 2013, Brain : a journal of neurology.

[64]  L. Martin,et al.  Aberrant Regulation of DNA Methylation in Amyotrophic Lateral Sclerosis: A New Target of Disease Mechanisms , 2013, Neurotherapeutics.

[65]  E. Rogaeva,et al.  Hypermethylation of the CpG island near the G4C2 repeat in ALS with a C9orf72 expansion. , 2013, American journal of human genetics.

[66]  C. Angelini,et al.  Disruption of skeletal muscle mitochondrial network genes and miRNAs in amyotrophic lateral sclerosis , 2013, Neurobiology of Disease.

[67]  D. Ruden,et al.  Identification of Epigenetically Altered Genes in Sporadic Amyotrophic Lateral Sclerosis , 2012, PloS one.

[68]  Janel O. Johnson,et al.  Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study , 2012, The Lancet Neurology.

[69]  R. Giffard,et al.  miR-181 regulates GRP78 and influences outcome from cerebral ischemia in vitro and in vivo , 2012, Neurobiology of Disease.

[70]  David Heckerman,et al.  A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD , 2011, Neuron.

[71]  D. Geschwind,et al.  Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS , 2011, Neuron.

[72]  E. Lai,et al.  Alternative miRNA biogenesis pathways and the interpretation of core miRNA pathway mutants. , 2011, Molecular cell.

[73]  Andrew J. Bannister,et al.  Regulation of chromatin by histone modifications , 2011, Cell Research.

[74]  E. Masliah,et al.  α-Synuclein Sequesters Dnmt1 from the Nucleus , 2011, The Journal of Biological Chemistry.

[75]  Yi Zhang,et al.  Dnmt3a-Dependent Nonpromoter DNA Methylation Facilitates Transcription of Neurogenic Genes , 2010, Science.

[76]  S. Petri,et al.  Differential Histone Deacetylase mRNA Expression Patterns in Amyotrophic Lateral Sclerosis , 2010, Journal of neuropathology and experimental neurology.

[77]  V. Choubey,et al.  PGC-1α and PGC-1β Regulate Mitochondrial Density in Neurons* , 2009, The Journal of Biological Chemistry.

[78]  R. Trent,et al.  A genome-wide analysis of brain DNA methylation identifies new candidate genes for sporadic amyotrophic lateral sclerosis , 2009, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[79]  P. Shaw,et al.  Clinical aspects of motor neurone disease , 2008 .

[80]  M. Panas,et al.  Phenotypic discordance in a pair of monozygotic twins with Huntington’s disease , 2008, Clinical genetics.

[81]  George Perry,et al.  Alzheimer disease, the two-hit hypothesis: an update. , 2007, Biochimica et biophysica acta.

[82]  R. Pamphlett,et al.  An epigenetic analysis of SOD1 and VEGF in ALS , 2007, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[83]  Jiandie D. Lin,et al.  PGC-1α protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription , 2006, Proceedings of the National Academy of Sciences.

[84]  J. Parvin,et al.  Alpha-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity. , 2006, Human molecular genetics.

[85]  Xiongwei Zhu,et al.  Alzheimer's disease: the two-hit hypothesis , 2004, The Lancet Neurology.

[86]  C. Rossi,et al.  Persistent activation of p38 mitogen-activated protein kinase in a mouse model of familial amyotrophic lateral sclerosis correlates with disease progression , 2003, Molecular and Cellular Neuroscience.

[87]  L. Ellerby,et al.  Coupling endoplasmic reticulum stress to the cell death program: role of the ER chaperone GRP78 , 2002, FEBS letters.

[88]  M. Biagioli,et al.  Epigenetics of Huntington's Disease. , 2017, Advances in experimental medicine and biology.

[89]  Kai Huang,et al.  Non-coding RNAs as regulators in epigenetics (Review). , 2017, Oncology reports.

[90]  R. Schneider,et al.  Lateral Thinking: How Histone Modifications Regulate Gene Expression. , 2016, Trends in genetics : TIG.

[91]  G. Fan,et al.  DNA Methylation and Its Basic Function , 2013, Neuropsychopharmacology.

[92]  J. Bennett,et al.  Impaired complex-I mitochondrial biogenesis in Parkinson disease frontal cortex. , 2012, Journal of Parkinson's disease.

[93]  B. Durham.  Novel histone deacetylase (HDAC) inhibitors with improved selectivity for HDAC2 and 3 protect against neural cell death , 2012 .

[94]  R. Kalaria,et al.  Alpha 1-antitrypsin and alpha 1-antichymotrypsin are in the lesions of Alzheimer's disease. , 1992, Neuroreport.

[95]  P. Heath,et al.  Degenerative Neurological and Neuromuscular Disease Dovepress the Genetics of Amyotrophic Lateral Sclerosis: Current Insights , 2022 .